GLP-1 Medications, Fertility & Pregnancy: What You Need to Know

Weight loss from GLP-1 medications can restore fertility in women with PCOS and obesity — increasing the risk of unintended pregnancy. Here's what every woman of reproductive age needs to know before starting these medications.

How Weight Loss Restores Fertility

Excess body weight disrupts the hormonal systems that regulate the menstrual cycle and ovulation. Fat tissue converts androgens to estrogens, raises insulin levels, and disrupts the delicate hormonal balance needed for regular ovulation. As a result, many women with obesity have irregular periods, anovulation (cycles without ovulation), or infertility.

When GLP-1 medications produce significant weight loss — even as little as 5–10% of body weight — these hormonal disruptions can correct. Menstrual cycles may become regular again. Ovulation may resume. Fertility can be unexpectedly and rapidly restored.

This is a real benefit for women trying to conceive — but it becomes a serious concern for women not planning a pregnancy who may not realize their fertility has changed.

Particular Concern in Women with PCOS

Women with polycystic ovary syndrome (PCOS) are at especially high risk of unintended pregnancy while on GLP-1 medications. PCOS is closely linked to insulin resistance and obesity, and many women with PCOS have been told by previous providers that they were unlikely to become pregnant without fertility treatment — often based on years of irregular cycles.

GLP-1 therapy improves insulin sensitivity, reduces androgen levels, and promotes weight loss — all of which directly address the underlying hormonal dysfunction in PCOS. Ovulation can resume within weeks to months of starting treatment, sometimes before a woman notices any significant change in her cycle regularity.

Why GLP-1 Medications Are Not Safe in Pregnancy

GLP-1 medications are classified as FDA Pregnancy Category X equivalent (Contraindicated) — meaning the risks to the developing fetus outweigh any potential benefits. Animal studies have shown fetal harm at clinically relevant doses, including:

• Reduced fetal growth
• Skeletal abnormalities
• Increased fetal deaths

Human pregnancy data is limited because women who become pregnant during clinical trials discontinue the medication. However, the animal data is concerning enough that all GLP-1 medications carry a strong contraindication to use during pregnancy.

Current guidelines recommend stopping GLP-1 medications:

• Ozempic / Wegovy / Rybelsus (semaglutide): At least 2 months before attempting to conceive
• Mounjaro / Zepbound (tirzepatide): At least 1 month before attempting to conceive

If you discover you are pregnant while taking a GLP-1 medication, stop it immediately and contact your obstetrician.

GLP-1 Medications and Oral Contraceptive Effectiveness

There is an additional layer of concern for women taking oral contraceptive pills (birth control pills): GLP-1 medications slow gastric emptying, which can affect how medications are absorbed from the gut. This may theoretically reduce the absorption and effectiveness of oral contraceptives.

The clinical significance of this interaction is still being studied, but some guidelines suggest:

• Women on oral contraceptives who start a GLP-1 medication should consider using a backup method (condoms) for the first 4 weeks and after any dose increase.
• Long-acting reversible contraception (IUD, implant, injectable) is not affected by GLP-1 medications and may be preferable for women who need highly reliable contraception.

Discuss this with both your endocrinologist and your gynecologist or primary care provider.

If You Want to Become Pregnant

GLP-1 medications can actually help women with PCOS and obesity who are trying to conceive — by restoring ovulation and improving metabolic health before pregnancy. However, the medications themselves must be stopped before pregnancy. A reasonable approach for women planning pregnancy:

1. Use GLP-1 therapy to achieve meaningful weight loss and metabolic improvement
2. Discuss a timeline for discontinuing the medication with your endocrinologist
3. Stop the medication per recommended washout guidelines (2 months for semaglutide)
4. Begin trying to conceive after the washout period
5. Maintain healthy diet and exercise habits — weight regain during pregnancy planning is common

What to Do Now

If you are a woman of reproductive age starting a GLP-1 medication:

• ✅ Tell your doctor about your contraceptive use and pregnancy plans
• ✅ If you do not want to become pregnant, use reliable contraception — and consider non-oral methods
• ✅ If you have PCOS or have been told you may have fertility challenges, do not assume those challenges remain while on GLP-1 therapy
• ✅ If you want to become pregnant in the future, plan your medication discontinuation timeline with your endocrinologist well in advance
• ✅ If you think you may be pregnant, stop the medication immediately and contact your OB